Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -122.19% is 67% below its 5-year average of -73.38%, around the middle of its 5-year range (-204.42%–-31.44%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.69% below its 12-month average of -114.53%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -122.19%.
RETURN ON EQUITY (ROE)
-122.19%
RETURN ON EQUITY (ROE) AVG TTM
-114.53%
RETURN ON EQUITY (ROE) AVG 3Y
-75.59%
RETURN ON EQUITY (ROE) AVG 5Y
-73.38%
RETURN ON EQUITY (ROE) AVG 10Y
-104.55%
RETURN ON EQUITY (ROE) AVG 15Y
-123.33%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-6.69%
CURRENT VS 3Y AVG
-61.65%
CURRENT VS 5Y AVG
-66.52%
CURRENT VS 10Y AVG
-16.88%
CURRENT VS 15Y AVG
+0.92%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.41%
median of 670 covered companies
CURRENT VS SECTOR MEDIAN
-202.42%
vs the sector median at left
InspireMD, Inc.
Market Cap
$28.40M
Return on Equity (ROE)
-122.19%
TTM Avg
-114.53%
3Y Avg
-75.59%
5Y Avg
-73.38%
Market Cap
$28.49M
Return on Equity (ROE)
-124.64%
TTM Avg
-100.64%
3Y Avg
-80.07%
5Y Avg
-67.08%
Market Cap
$27.55M
Return on Equity (ROE)
-65.05%
TTM Avg
-525.23%
3Y Avg
-779.21%
5Y Avg
-536.29%
Market Cap
$29.48M
Return on Equity (ROE)
-120.40%
TTM Avg
-43.89%
3Y Avg
-83.08%
5Y Avg
-65.54%
Market Cap
$29.60M
Return on Equity (ROE)
-117.69%
TTM Avg
-1443.79%
3Y Avg
-971.02%
5Y Avg
-813.57%
Market Cap
$29.16M
Return on Equity (ROE)
N/A
TTM Avg
78.98%
3Y Avg
134.04%
5Y Avg
114.40%
Market Cap
$29.99M
Return on Equity (ROE)
N/A
TTM Avg
10.32%
3Y Avg
-262.53%
5Y Avg
-267.00%
Market Cap
$30.23M
Return on Equity (ROE)
-132.18%
TTM Avg
-94.77%
3Y Avg
-38.62%
5Y Avg
-46.78%
Market Cap
$30.31M
Return on Equity (ROE)
-111.81%
TTM Avg
-29.10%
3Y Avg
-257.52%
5Y Avg
159.26%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InspireMD, Inc. (NSPR) | $28.40M | -122.19% | -114.53% | -75.59% | -73.38% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.49M | -124.64% | -100.64% | -80.07% | -67.08% |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.55M | -65.05% | -525.23% | -779.21% | -536.29% |
| Context Therapeutics Inc. (CNTX)vs › | $29.48M | -120.40% | -43.89% | -83.08% | -65.54% |
| Quantum Cyber N.V. (QUCY)vs › | $29.60M | -117.69% | -1443.79% | -971.02% | -813.57% |
| OneMedNet Corporation (ONMD)vs › | $29.16M | N/A | 78.98% | 134.04% | 114.40% |
| MDxHealth S.A. (MDXH)vs › | $29.99M | N/A | 10.32% | -262.53% | -267.00% |
| CervoMed Inc. (CRVO)vs › | $30.23M | -132.18% | -94.77% | -38.62% | -46.78% |
| GridAI Technologies Corp. (GRDX)vs › | $30.31M | -111.81% | -29.10% | -257.52% | 159.26% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.69M | -116.14% | -228.74% | 113.10% | 76.03% |
ROE
-122.2%
ROA
-86.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -122.19% |
| 2026-03-31 | -85.59% |
| 2025-12-31 | -88.38% |
| 2025-09-30 | -72.06% |
| 2025-06-30 | -204.42% |
| 2025-03-31 | -127.50% |
| 2024-12-31 | -88.69% |
| 2024-09-30 | -68.28% |
| 2024-06-30 | -54.58% |
| 2024-03-31 | -64.67% |
| 2023-12-31 | -50.42% |
| 2023-09-30 | -44.75% |
| 2023-06-30 | -39.96% |
| 2023-03-31 | -136.05% |
| 2022-12-31 | -106.31% |
| 2022-09-30 | -81.13% |
| 2022-06-30 | -67.15% |
| 2022-03-31 | -54.39% |
| 2021-12-31 | -44.49% |
| 2021-09-30 | -39.59% |
| 2021-06-30 | -31.44% |
| 2021-03-31 | -26.87% |
| 2020-12-31 | -86.69% |
| 2020-09-30 | -81.99% |
| 2020-06-30 | -68.75% |
| 2020-03-31 | -253.41% |
| 2019-12-31 | -186.51% |
| 2019-09-30 | -122.80% |
| 2019-06-30 | -172.89% |
| 2019-03-31 | -142.87% |
| 2018-12-31 | -82.62% |
| 2018-09-30 | -59.60% |
| 2018-06-30 | -161.10% |
| 2018-03-31 | -792.05% |
| 2017-12-31 | -309.46% |
| 2017-09-30 | -232.88% |
| 2017-06-30 | -151.93% |
| 2017-03-31 | -109.02% |
| 2016-12-31 | -209.15% |
| 2016-09-30 | -151.73% |
| 2015-06-30 | -869.32% |
| 2015-03-31 | -451.98% |
| 2014-03-31 | -688.07% |
| 2013-09-30 | -197.55% |
| 2013-06-30 | -181.70% |
| 2012-06-30 | -326.72% |
| 2012-03-31 | -331.32% |
| 2011-12-31 | -217.13% |
| 2011-09-30 | -78.33% |
| 2011-06-30 | -58.05% |
| 2011-03-31 | -24.77% |
| 2010-03-31 | -154.24% |